• 1
    D’Amato G, Spieksma FT, Bonini S. Allergenic pollen and pollinosis in Europe. Oxford: Blackwell Scientific Publications, 1991: 1226.
  • 2
    Mari A, Wallner M, Ferreira F. Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4). Clin Exp Allergy 2003;33:14191428.
  • 3
    Breiteneder H, Pettenburger K, Bito A, Valenta R, Kraft D, Rumpold H et al. The gene coding for the major birch pollen allergen Betv1, is highly homologous to a pea disease resistance response gene. EMBO J 1989;8:19351938.
  • 4
    Ebner C, Schenk S, Najafian N, Siemann U, Steiner R, Fischer GW et al. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol 1995;154:19321940.
  • 5
    Ebner C, Siemann U, Najafian N, Scheiner O, Kraft D. Characterization of allergen (Bet v 1)-specific T cell lines and clones from non-allergic individuals. Int Arch Allergy Immunol 1995;107:183185.
  • 6
    Ferreira F, Hirtenlehner K, Jilek A, Godnik-Cvar J, Breiteneder H, Grimm R et al. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996;183:599609.
  • 7
    Buters JT, Kasche A, Weichenmeier I, Schober W, Klaus S, Traidl-Hoffmann C et al. Year-to-year variation in release of Bet v 1 allergen from birch pollen: evidence for geographical differences between West and South Germany. Int Arch Allergy Immunol 2007;145:122130.
  • 8
    American Academy of Allergy, Asthma and Immunology (AAAAI). The use of standardized allergen extracts. J Allergy Clin Immunol 1997;99:583586.
  • 9
    Norman PS. WHO-IUIS International Standards: advantages of these extracts. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1994;87:5964.
  • 10
    Van Ree R. A new start for allergen references and standardization based on purified (natural or recombinant) allergens and monoclonal and monospecific polyclonal antibodies. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1999;93:8790; discussion 90–2.
  • 11
    Arntzen FC, Wilhelmsen TW, Lowenstein H, Gjesing B, Maasch HJ, Stromberg R et al. The international collaborative study on the first international standard of birch (Betula verrucosa)-pollen extract. J Allergy Clin Immunol 1989;83:6682.
  • 12
    Van Ree R. The CREATE project: EU support for the improvement of allergen standardization in Europe. Allergy 2004;59:571574.
  • 13
    Van Ree R, Chapman MD, Ferreira F, Vieths S, Bryan D, Cromwell O et al. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy 2008;63:310326.
  • 14
    Batard T, Didierlaurent A, Chabre H, Mothes N, Bussieres L, Bohle B et al. Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy. Int Arch Allergy Immunol 2005;136:239249.
  • 15
    Bairoch A, Apweiler R, Wu CH, Barker WC, Boeckmann B, Ferro S et al. The Universal Protein Resource (UniProt). Nucleic Acids Res 2005;33(Database issue):D154D159.
  • 16
    Wen J, Arakawa T, Philo JS. Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions. Anal Biochem 1996;240:155166.
  • 17
    Harding SE, Jumel K. Light scattering. Curr Protoc Protein Sci 2001; Volume 1; Chapter 7; Unit 7.8:7.8.1-7.8.14.
  • 18
    Statistical analysis of results of biological assays and tests. In European Pharmacopoeia 6.0. Council of Europe, Strasbourg, France: Council of Europe, 2008. p.571600.
  • 19
    Wambre E, Van Overtvelt L, Maillere B, Humphreys R, Von Hofe E, Ferhat L et al. Single cell assessment of allergen-specific T cell responses with MHC class II peptide tetramers: methodological aspects. Int Arch Allergy Immunol 2008;146:99112.
  • 20
    Pauli G, Larsen TH, Rak S, Horak F, Pastorello E, Valenta R et al. Efficacy of recombinant birch pollen vaccine for the treatment of birch allergic rhinoconjuctivitis. J Allergy Clin Immunol 2008;122:951960.